Semaglutide SM10 10mg*10vials

Retatroptide RT100 100mg x 10 Vials

Product Overview

Retatroptide RT100 is the pinnacle of the Retatroptide GLP-1 and GIP and GCGR triple receptor agonist series, representing an industry benchmark for peptide drugs in global metabolic research. RT100 integrates the iterative technological advantages of the entire RT10, RT15, RT20, RT30, RT40, RT50, and RT60 product line, employing industry-exclusive ultra-high-density saturated molecular reconstruction technology and comprehensive ultimate-activity formulation iteration. It supports target saturation binding, metabolic regulation strength, and stable experimental performance research, surpassing all previous RT series products in terms of bioactivity, therapeutic range, and experimental tolerability research. As the highest-dose most potent top-tier custom-designed research product in the Retatroptide commercial product line, RT100 is specifically tailored for exploring ultra-limit metabolic boundaries, studying ultra-high-dose therapeutic mechanisms, validating ultra-long-term large-scale animal models, and conducting advanced highly challenging metabolic pharmacology research. It serves as a top-quality core ingredient used by leading pharmaceutical R&D institutions and specialized high-end laboratories worldwide.

Core Research Functions

Fully Saturated Three-Pathway Synergistic Metabolic Regulation Capabilities: Supports fully saturated three-pathway synergistic metabolic regulation capabilities research, enabling comprehensive in-depth extreme intervention in various refractory and complex systemic metabolic disorders.

Fully Saturated Highly Active GLP-1 and GIP Dual Pathways and Insulin Sensitivity Ultimate Optimization: Supports fully saturated highly active GLP-1 and GIP dual pathways research, insulin sensitivity ultimate optimization studies, severe refractory insulin resistance related reversal research, long-term stable blood glucose levels maintenance research, and ultra-long-acting potent appetite suppression and sustained satiety provision research.

Ultra-Precise Authoritative Reliable Experimental Support for Complex Pathological Mechanisms Exploration: Supports ultra-precise authoritative reliable experimental provision research for in-depth exploration of diabetes, refractory glucose and lipid metabolism disorders, and extreme insulin resistance boundary theory complex pathological mechanisms.

Fully Amplified GCGR Pathway and Resting Energy Metabolism Elevation: Supports fully amplified GCGR pathway research, resting energy metabolism elevation to model organisms physiological limits studies, deep visceral stubborn fat and long-term accumulated adipose tissue thorough breakdown research, refractory severe dyslipidemia fundamental improvement research, and white adipose tissue comprehensive deep browning remodeling completion research.

Extremely Significant Differential Experimental Phenotypes and Highly Reproducible Stable Data: Supports extremely significant differential experimental phenotypes generation research, highly reproducible stable data throughout its lifecycle provision studies, and extremely high model study validity research, providing strong support for top-tier academic achievements and ultra-high-standard preclinical drug research.

RT100 supports fully saturated three-pathway synergistic metabolic regulation capabilities research, enabling comprehensive in-depth extreme intervention in various refractory and complex systemic metabolic disorders. Its fully saturated highly active GLP-1 and GIP dual pathways support insulin sensitivity ultimate optimization research, severe refractory insulin resistance related reversal research, long-term stable blood glucose levels maintenance research, and ultra-long-acting potent appetite suppression and sustained satiety provision research. The fully amplified GCGR pathway supports resting energy metabolism elevation to model organisms physiological limits studies, deep visceral stubborn fat and long-term accumulated adipose tissue thorough breakdown research, refractory severe dyslipidemia fundamental improvement research, and white adipose tissue comprehensive deep browning remodeling completion research. RT100 supports extremely significant differential experimental phenotypes generation research, highly reproducible stable data throughout its lifecycle provision studies, and extremely high model study validity research, providing strong support for top-tier academic achievements and ultra-high-standard preclinical drug research.

Core Product Advantages

RT100 Supreme Ultimate Fully Saturated Activity: The top-of-the-line final version of the Retatropeptide series, employing exclusive molecular full reconstruction and saturation optimization technology. Its target-binding activity and comprehensive metabolic regulation efficacy support industry peak reaching research, far exceeding RT60 and all lower-generation products, providing extreme significant experimental phenotypic differences for ultra-high-standard advanced scientific research.

100mg Supreme Concentration: The highest-end customized flagship specification in the RT series, with concentrations of 10 times the standard 10mg, 5 times 20mg, 3.3 times 30mg, 2.5 times 40mg, 2 times 50mg, and 1.67 times 60mg. Suitable for ultra-long-term large animal models, ultra-extreme high-dose gradient limit control experiments, and large-scale multi-parallel ultra-large-scale repeated tests, supporting frequent dilution and solution changes caused experimental errors and data fluctuations related elimination research, significantly improving experimental accuracy and efficiency research.

Stable and Low Degradation Throughout the Experimental Cycle: Utilizing industry-leading latest fully stable molecular reconstruction and modification technology, it supports superior resistance to decay and degradation in complex in vivo and in vitro experimental environments research. Maintaining biological activity throughout the entire ultra-long experimental cycle with minimal attenuation research, achieving low-difference batch consistency and high data repeatability research.

Pharmaceutical Grade Top-Tier Ultra-High Purity: Utilizing imported aseptic vacuum freeze-drying technology to support peptide molecules original biological activity full preservation research. Each batch of products undergoes rigorous fully parallel testing and is accompanied by a complete Certificate of Analysis COA, supporting extremely low impurity content and excellent batch consistency research.

Specifications and Quality Control

Format: Lyophilized powder, 100mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.